Neoadjuvant chemotherapy increases the 5-year overall survival of patients with resectable cervical cancer: A systematic review and meta-analysis
Cervical cancer is a global health challenge in women. Neoadjuvant chemotherapy (NACT) is a recent prospect for alternative cervical cancer treatments. This study investigated the efficacy of NACT against resectable cervical cancer based on the medium and long-term survival of patients with the dise...
Saved in:
Main Authors: | Yunbao Xu (Author), Mengting Zhang (Author), Jiaying Zhang (Author), Derry Minyao Ng (Author), Xiaoxiao Chen (Author), Yuexiu Si (Author), Yetan Shi (Author), Xiangyuan Li (Author), Danyi Mao (Author), Lu Yang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SGLT-2i and Risk of Malignancy in Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials
by: Nanjing Shi, et al.
Published: (2021) -
Evaluation of the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer
by: Wang H, et al.
Published: (2020) -
Neoadjuvant Chemotherapy Current Applications in Clinical Practice
Published: (2012) -
Neoadjuvant Chemotherapy Increasing Relevance in Cancer Management
Published: (2013) -
Advanced Cervical Cancer: Leveraging the Historical Threshold of Overall Survival
by: Eduardo Paulino, et al.
Published: (2021)